We are live on ! Find out more
PSTV icon

Plus Therapeutics
PSTV

15 hedge funds and large institutions have $2.03M invested in Plus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

36% more funds holding

Funds holding: 11 → 15 (+4)

0.01% more ownership

Funds ownership: 0.02% → 0.03% (+0.01%)

18% less capital invested

Capital invested by funds: $2.48M → $2.03M (-$454K)

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$317K
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$311K
3
Citadel Advisors
Citadel Advisors
Florida
+$128K
4
Two Sigma Investments
Two Sigma Investments
New York
+$126K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$50.7K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$749K – – –
Two Sigma Advisers
2
Two Sigma Advisers
New York
$277K +$311K +540 +329%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$271K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$217K +$317K +551 New
BlackRock
5
BlackRock
New York
$136K +$1.15K +2 +0.6%
Two Sigma Investments
6
Two Sigma Investments
New York
$104K +$126K +219 +498%
Citadel Advisors
7
Citadel Advisors
Florida
$87K +$128K +222 New
State Street
8
State Street
Massachusetts
$36K – – –
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$35K +$50.7K +88 New
Northern Trust
10
Northern Trust
Illinois
$34K – – –
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$27K – – –
Creative Planning
12
Creative Planning
Kansas
$22K +$4.03K +7 +14%
TSS
13
Two Sigma Securities
New York
$15K +$21.3K +37 New
Osaic Holdings
14
Osaic Holdings
Arizona
$11K +$2.31K +4 +17%
Morgan Stanley
15
Morgan Stanley
New York
$4K +$5.76K +10 New
FP
16
Financial Perspectives
Minnesota
$1 – – –
Bank of America
17
Bank of America
North Carolina
– -$4K -6 Closed

PSTV Hedge Fund Activity: Q4 2021 in Review

15 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q4 2021, worth a combined $2.03M — down 18% from $2.48M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PSTV positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $317K. The largest seller was Bank of America, exiting entirely with an estimated $4K sold.

  • 15 institutional investors held Plus Therapeutics (PSTV) as of Q4 2021, up from 11 in Q3 2021.
  • Funds reported $2.03M of Plus Therapeutics stock for Q4 2021, down 18% quarter-over-quarter.
  • 5 funds opened new Plus Therapeutics positions in Q4 2021 and 1 closed out, a net change of +4 holders.
  • The largest Plus Therapeutics buyer in Q4 2021 was Renaissance Technologies, an estimated $317K added.
  • The largest Plus Therapeutics seller in Q4 2021 was Bank of America, an estimated $4K sold.

Based on aggregated 13F filings for Q4 2021.